Comparative effectiveness of cycling of tumor necrosis factor-${\alpha}$ (TNF-${\alpha}$) inhibitors versus switching to non-TNF biologics in rheumatoid arthritis patients with inadequate response to TNF-${\alpha}$ inhibitor using a Bayesian approach